Rosewell Park Cancer Institute — Buffalo, New York

Rosewell Park Cancer Institute is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Rosewell Park Cancer Institute has participated in 6 clinical trials with 3 currently active.

Therapeutic areas: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes.

Sponsors: Center for International Blood and Marrow Transplant Research, Bristol-Myers Squibb, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rosewell Park Cancer Institute?

Rosewell Park Cancer Institute has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rosewell Park Cancer Institute conducted?

Rosewell Park Cancer Institute has 6 clinical trials on record, with 3 currently active. Their work covers Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes.

Is Rosewell Park Cancer Institute accredited by Crixeo Health?

Yes — Rosewell Park Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rosewell Park Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.